Evidence map›Paper›PMID 27812766›Full record

ArticleBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2016

Hypoxia-selective inhibition of angiogenesis development by NAMI-A analogues.

Maria Oszajca, Guillaume Collet, Grażyna Stochel, Claudine Kieda, Małgorzata Brindell

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Hypoxia-active nanoparticles used in tumor theranostic.International journal of nanomedicine · 2019
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maria OszajcaFaculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060, Kraków, Poland. maria.oszajca@chemia.uj.edu.pl.
Guillaume ColletCentre for Molecular Biophysics, Cell Recognition and Glycobiology, UPR4301-CNRS, rue Charles Sadron, 45071, Orléans, France.
Grażyna StochelFaculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060, Kraków, Poland.
Claudine KiedaCentre for Molecular Biophysics, Cell Recognition and Glycobiology, UPR4301-CNRS, rue Charles Sadron, 45071, Orléans, France. claudine.kieda@cnrs-orleans.fr.
Małgorzata BrindellFaculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060, Kraków, Poland.
Jagiellonian University · PLCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antimetastatic ruthenium(III) complex (H

Indexed as

Angiogenesis InhibitorsAntineoplastic AgentsCell HypoxiaCell LineCell MovementDimethyl SulfoxideDrug Evaluation, PreclinicalGene Expression RegulationHumansNeovascularization, PathologicOrganometallic CompoundsRutheniumRuthenium CompoundsTumor HypoxiaAngiogenesis InhibitorsAntineoplastic AgentsDimethyl Sulfoxideimidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III)Organometallic CompoundsRutheniumRuthenium CompoundsAngiogenesisEndothelial cellsHypoxiaNAMI-A analoguesRuthenium complexes

Identifiers

PMID27812766
PMCPMC5116311
OpenAlexW2548739388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.